ARCHIVES

New Therapies For Genitourinary Cancers In Clinical Testing Presented At ASCO

This article is from The Cancer Letter archive.

Vol. 26 No. 7 | July 25, 2003

Download PDF Visit The Full Archive

Related Articles

Votrient Trial Meets PFS Endpoint In Epithelial Ovarian Cancer

June 28, 2013

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

March 12, 2010

In Brief: Kripke, Fidler To Leave FCRF for M.D. Anderson; George Todaro Takes Job With New Seattle Firm

March 4, 1983

DeVita Changes Mind On OSP Phase Out Reasons, But Presses for “Internalizing” Coordinating Portfolio

January 1, 1988

Expert Review Of ImClone Protocol Concludes C225 Approval Unlikely.

February 15, 2002

NCI Advisors Approve New Grant Programs Worth $100 Million

March 27, 2009